Redox regulation of sodium and calcium handling

Antioxidants and Redox Signaling

Volumn 18, Issue 9, 2013, Pages 1063-1077

  Wagner, Stefan ^a   Rokita, Adam G ^a,b   Anderson, Mark E ^b   Maier, Lars S ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; GELATINASE B; ION CHANNEL; PHOSPHATASE 1 INHIBITOR 1; PHOSPHOLAMBAN; PHOSPHOLEMMAN; PROTEIN; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR 2; SODIUM; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHEMICAL MODIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SODIUM TRANSPORT;

ARRHYTHMIAS, CARDIAC; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; HEART FAILURE; HUMANS; ION CHANNEL GATING; ION TRANSPORT; MITOCHONDRIA, HEART; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCARDIUM; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; SARCOLEMMA; SODIUM; SODIUM CHANNELS; SUPEROXIDES;

EID: 84874093502     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4818     Document Type: Review

References (154)

1. Abramson JJ and Salama G. Critical sulfhydryls regulate calcium release from sarcoplasmic reticulum. J Bioenerg Biomembr 21: 283-294, 1989.
2. Ago T, Kuroda J, Pain J, Fu C, Li H, and Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myo-cytes. Circ Res 106: 1253-1264, 2010.
3. Akar FG, Aon MA, Tomaselli GF, and O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 115: 3527-3535, 2005.
4. Akki A, Zhang M, Murdoch C, Brewer A, and Shah AM. NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47: 15-22, 2009.
5. Anilkumar N, Sirker A, and Shah AM. Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure. Front Biosci 14: 3168-3187, 2009.
6. Anzai K, Ogawa K, Kuniyasu A, Ozawa T, Yamamoto H, and Nakayama H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem Biophys Res Comm 249: 938-942, 1998.
7. Aon MA, Cortassa S, and O'Rourke B. The fundamental organization of cardiac mitochondria as a network of coupled oscillators. Biophys J 91: 4317-4327, 2006.
8. Aon MA, Cortassa S, Marban E, and O'Rourke B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 278: 44735-44744, 2003.
9. Armoundas AA, Hobai IA, Tomaselli GF, Winslow RL, and O'Rourke B. Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res 93: 46-53, 2003.
10. V1.5 gating by multiple phos-phorylation sites. J Biol Chem 287: 19856-19869, 2012.
11. 2+-exchanger in heart failure. Cardiovasc Res 57: 986-995, 2003.
12. i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 57: 1015-1024. 2003.
13. +-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res 65: 83-92, 2005.
14. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, and Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416: 337-339, 2002.
15. Barrington P, Meier C, and Weglicki W. Abnormal electrical-activity induced by free-radical generating systems in isolated cardiocytes. J Mol Cell Cardiol 20: 1163-1178, 1988.
16. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ, and de Tombe PP. Augmented protein kinase C-a-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res 101: 195-204, 2007.
17. + in normal and failing cardiac myocytes. Ann NY Acad Sci 1080: 165-177, 2006.
18. Bers DM. Altered cardiac myocyte Ca regulation In heart failure. Physiology (Bethesda) 21: 380-387, 2006.
19. V1.2 channel is modulated by calmodulin kinase II-dependent phosphorylation of S1512 and S1570. Proc Natl Acad Sci USA 107: 10285-10289, 2010.
20. Bogoyevitch MA, Parker PJ, and Sugden PH. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and en-dothelin. Circ Res 72: 757-767, 1993.
21. 2 and dithiothreitol. Am J Physiol 267: H1010-1016, 1994.
22. 2+-sensitive isoforms in the failing human heart. Circulation 99: 384-391, 1999.
23. Braz JC, Gregory K, Pathak A, Zhao W, Sahin B, Klevitsky R, Kimball TF, Lorenz JN, Nairn AC, Liggett SB, Bodi I, Wang S, Schwartz A, Lakatta EG, DePaoli-Roach AA, Robbins J, Hewett TE, Bibb JA, Westfall MV, Kranias EG, and Molkentin JD. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10: 248-254, 2004.
24. Brennan J, Bardswell S, Burgoyne J, Fuller W, Schroder E, Wait R, Begum S, Kentish J, and Eaton P. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem 281: 21827-21836, 2006.
25. Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, Hu K, Hofmann U, Bonz A, Frantz S, Cartwright EJ, Neyses L, Maier LS, Maier SK, Renné T, Schuh K, and Ritter O. Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100: e32-44, 2007.
26. Campbell DL, Stamler JS, and Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108: 277-293, 1996.
27. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, and Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001.
28. 2+ channels. Annu Rev Cell Dev Biol 16: 521-555, 2000.
29. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW 2nd, and Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA 98: 11114-11119, 2001.
30. Churchill EN and Mochly-Rosen D. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans 35: 1040-1042, 2007.
31. Coetzee WA and Opie LH. Effects of oxygen free radicals on isolated cardiac myocytes from guinea-pig ventricle: Elec-trophysiological studies. J Mol Cell Cardiol 24: 651-663, 1992.
32. Dai DF and Rabinovitch P. Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in an-giotensin-II treated mouse hearts. Autophagy 7: 917-918, 2011.
33. Dai DF, Chen T, Szeto H, Nieves-Cintrón M, Kutyavin V, Santana LF, and Rabinovitch PS. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomy-opathy. J Am Coll Cardiol 58: 73-82, 2011.
34. Dai DF, Hsieh EJ, Liu Y, Chen T, Beyer RP, Chin MT, MacCoss MJ, and Rabinovitch PS. Mitochondrial proteome remodelling in pressure overload-induced heart failure: The role of mitochondrial oxidative stress. Cardiovasc Res 93: 79-88, 2012.
35. Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintrón M, Chen T, Marcinek DJ, Dorn GW, 2nd, Kang YJ, Prolla TA, Santana LF, and Rabinovitch PS. Mitochondrial oxi-dative stress mediates angiotensin II-induced cardiac hypertrophy and Gaq overexpression-induced heart failure. Circ Res 108: 837-846, 2011.
36. De Jongh KS, Murphy BJ, Colvin AA, Hell JW, Takahashi M, and Catterall WA. Specific phosphorylation of a site in the full-length form of the a1 subunit of the cardiac L-type calcium channel by adenosine 3', 5'-cyclic monophosphate-dependent protein kinase. Biochemistry 35: 10392-10402, 1996.
37. Despa S, Bossuyt J, Han F, Ginsburg KS, Jia LG, Kutchai H, Tucker AL, and Bers DM. Phospholemman-phosphoryla-tion mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 97: 252-259, 2005.
38. 2+ transient of failing human ventricular myocytes. Circ Res 84: 435-444, 1999.
39. Dorn GW and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115: 527-537, 2005.
40. Duquesnes N, Lezoualc'h F, and Crozatier B. PKCd and PKCe: Foes of the same family or strangers? J Mol Cell Cardiol 51: 665-673, 2011.
41. Dzhura I, Wu Y, Colbran RJ, Balser JR, and Anderson ME. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol 2: 173-177, 2000.
42. 2+ and ATP. J Membr Biol 163: 9-18, 1998.
43. Erickson JR, He BJ, Grumbach IM, and Anderson ME. CaMKII in the cardiovascular system: Sensing redox states. Physiol Rev 91: 889-915, 2011.
44. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, and Anderson ME. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133: 462-474, 2008.
45. 2+ release channel from skeletal muscle sarcoplasmic reticulum. J Biol Chem 270: 25557-25563, 1995.
46. 1C subunits by redox agents and hyp-oxia. J Physiol 514: 629-637, 1999.
47. Frohnwieser B, Chen L, Schreibmayer W, and Kallen R. Modulation of the human cardiac sodium channel a-sub-unit by cAMP-dependent protein kinase and the responsible sequence domain. J Physiol (Lond) 498: 309-318, 1997.
48. Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, Fessel J, Amarnath V, Anderson ME, Boyden PA, Viswa-nathan PC, Roberts LJ, 2nd, and Balser Jr. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res 97: 1262-1269, 2005.
49. 2 in quiescent isolated rat cardiomyocytes. Basic Res Cardiol 96: 623-629, 2001.
50. 2+ currents in isolated guinea-pig ventricular myocytes. Eur J Pharmacol 292: 337-340, 1995.
51. Goldhaber JI, Ji S, Lamp ST, Weiss JN. Effects of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricle. Implications for ischemia and reperfusion injury. J Clin Invest 83: 1800-1809, 1989.
52. 2+ exchange in ventricular myocytes. Am J Physiol 271: H823-833, 1996.
53. 2+-independent and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Nat Acad Sci 86: 6758-6762, 1989.
54. 2+ channel facilitation mediated by phosphorylation of the beta sub-unit by CaMKII. Mol Cell 23: 641-650, 2006.
55. Haase H, Bartel S, Karczewski P, Morano I, and Krause EG. In-vivo phosphorylation of the cardiac L-type calcium channel beta-subunit in response to catecholamines. Mol Cell Biochem 163-164: 99-106, 1996.
56. Hallaq H, Yang Z, Viswanathan P, Fukuda K, Shen W, Wang D, Wells K, Zhou J, Yi J, and Murray K. Quantitation of protein kinase A-mediated trafficking of cardiac sodium channels in living cells. Cardiovasc Res 72: 250-261, 2006.
57. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99: 641-648, 1999.
58. He BJ, Joiner ML, Singh MV, Luczak ED, Swaminathan PD, Koval OM, Kutschke W, Allamargot C, Yang J, Guan X, Zimmerman K, Grumbach IM, Weiss RM, Spitz DR, Sig-mund CD, Blankesteijn WM, Heymans S, Mohler PJ, and Anderson ME. Oxidation of CaMKII determines the car-diotoxic effects of aldosterone. Nat Med 17: 1610-1618, 2011.
59. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G, and Shah AM. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41: 2164-2171, 2003.
60. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M, Labeit S, and Granzier H. PKC phosphorylation of titin's PEVK element: A novel and conserved pathway for modulating myocardial stiffness. Circ Res 105: 631-638, 2009.
61. 2+ exchanger. Nature 352: 715-718, 1991.
62. Hill MF and Singal PK. Right and left myocardial antioxi-dant responses during heart failure subsequent to myo-cardial infarction. Circulation 96: 2414-2420, 1997.
63. House C and Kemp BE. Protein kinase C contains a pseu-dosubstrate prototope in its regulatory domain. Science 238: 1726-1728, 1987.
64. 2+ channels by S-nitrosothiol nitric oxide donors. Circ Res 81: 742-752, 1997.
65. 2+ transients of mouse heart myocytes conditionally expressing PKCb. Am J Physiol Cell Physiol 280: C1114-1120, 2001.
66. 2+ signals for facilitation. J Cell Biol 171: 537-547, 2005.
67. 1-adrenergic regulation. Proc Natl Acad Sci USA 103: 16574-16579, 2006.
68. IV-spec-trin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest 120: 3508-3519, 2010.
69. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K, and Take-shita A. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86: 152-157, 2000.
70. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Arimura K, Egashira K, and Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85: 357-363, 1999.
71. 2+ exchanger via protein kinase C. J Biol Chem 271: 13609-13615, 1996.
72. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, and Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-a. J Biol Chem 273: 6297-6302, 1998.
73. Kassmann M, Hansel A, Leipold E, Birkenbeil J, Lu SQ, Hoshi T, and Heinemann SH. Oxidation of multiple me-thionine residues impairs rapid sodium channel inactiva-tion. Pflugers Arch 456: 1085-1095, 2008.
74. 2+ exchange of isolated sarcolemmal membrane: Effects of insulin, oxidants and insulin deficiency. Mol Cell Biochem 83: 15-25, 1988.
75. +-ATPase. Am J Physiol 252: H252-257, 1987.
76. + increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 121: 1606-1613, 2010.
77. V1.2 b-subunit coordinates CaMKII-triggered cardiomyocyte death and after-depolarizations. Proc Natl Acad Sci USA 107: 4996-5000, 2010.
78. 2+ ATPase activity of cardiac sarcoplasmic reticulum. Arch Biochem Biophys 261: 447-457, 1988.
79. +-ATPase: Inactivation by neutrophil-derived free radicals and oxidants. Am J Physiol 259: H1330-1336, 1990.
80. 2+/calmodulin-dependent protein kinase. J Biol Chem 260: 6427-6433, 1985.
81. Kuroda J, Ago T, Matsushima S, Zhai P, Schneider MD, and Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA 107: 15565-15570, 2010.
82. Lacampagne A, Duittoz A, Bolanos P, Peineau N, and Argibay JA. Effect of sulfhydryl oxidation on ionic and gating currents associated with L-type calcium channels in isolated guinea-pig ventricular myocytes. Cardiovasc Res 30: 799-806, 1995.
83. Liu G, Abramson JJ, Zable AC, and Pessah IN. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethyla-mino-3-(4-Vmaleimidylphenyl)-4-methylcoumarin. Mol Pharmacol 45: 189-200, 1994.
84. Liu M, Liu H, and Dudley SC Jr. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ Res 107: 967-974, 2010.
85. Maack C, Dabew ER, Hohl M, Schäfers HJ, and Böhm M. Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning. Circ Res 105: 811-817, 2009.
86. Maack C, Kartes T, Kilter H, Schäfers HJ, Nickenig G, Böhm M, and Laufs U. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment. Circulation 108: 1567-1574, 2003.
87. 2+/calmodulin-depen-dent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 73: 631-640, 2007.
88. 2+ release. Circ Res 92: 904-911, 2003.
89. Maier LS. CaMKII regulation of voltage-gated sodium channels and cell excitability. Heart Rhythm 8: 474-477, 2011.
90. Malhotra A, Kang BP, Opawumi D, Belizaire W, and Meggs LG. Molecular biology of protein kinase C signaling in cardiac myocytes. Mol Cell Biochem 225: 97-107, 2001.
91. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, and Tedgui A. Elevated levels of 8-iso-prostaglandin F2a in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97: 1536-1539, 1998.
92. Marengo JJ, Hidalgo C and Bull R. Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells. Biophys J 74: 1263-1277, 1998.
93. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Take-shima H, Narumiya S, and Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sen-sitive calcium channel. Nature 340: 230-233, 1989.
94. Mochly-Rosen D, Khaner H, and Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA 88: 3997-4000, 1991.
95. 2+-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic Biol Med 22: 37-47, 1997.
96. Murphy AJ. Sulfhydryl group modification of sarcoplasmic reticulum membranes. Biochemistry 15: 4492-4496, 1976.
97. Murphy BJ, Rogers J, Perdichizzi AP, Colvin AA, and Catterall WA. cAMP-dependent phosphorylation of two sites in the a subunit of the cardiac sodium channel. J Biol Chem 271: 28837-28843, 1996.
98. + channel. Circ Res 80: 370-376, 1997.
99. 2+ exchanger. J Biol Chem 274: 910-917, 1999.
100. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
101. Palace V, Kumar D, Hill MF, Khaper N, and Singal PK. Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J Mol Cell Cardiol 31: 193-202, 1999.
102. Perrelli MG, Pagliaro P, and Penna C. Ischemia/reperfu-sion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World J Cardiol 3: 186-200, 2011.
103. Piacentino V, 3rd, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM, and Houser SR. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92: 651-658, 2003.
104. i and contractility in nonfailing and failing human myocardium. Circulation 106: 447-453, 2002.
105. Puri TS, Gerhardstein BL, Zhao XL, Ladner MB, and Hosey MM. Differential effects of subunit interactions on protein kinase A-and C-mediated phosphorylation of L-type calcium channels. Biochemistry 36: 9605-9615, 1997.
106. + channel in-activation gate is required for modulation by protein kinase C. J Gen Physiol 108: 375-379, 1996.
107. + channels expressed in a mammalian cell line and in ventricular myocytes by protein kinase C. Proc Nat Acad Sci 91: 3289-3293, 1994.
108. Ramirez-Correa GA, Cortassa S, Stanley B, Gao WD, Murphy AM. Calcium sensitivity, force frequency relationship and cardiac troponin I: Critical role of PKA and PKC phosphorylation sites. J Mol Cell Cardiol 48: 943-953, 2010.
109. Reeves JP, Bailey CA, and Hale CC. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem 261: 4948-4955, 1986.
110. + channels in rat ventricular myocytes. J Mol Cell Cardiol 34: 1623-1632, 2002.
111. + exchange in neonatal rat cardiac myocytes. Circ Res 82: 1053-1062, 1998.
112. Sag CM, Köhler AC, Anderson ME, Backs J, and Maier LS. CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myo-cytes. J Mol Cell Cardiol 51: 749-759, 2011.
113. 2+ exchanger. J Biol Chem 275: 182-188, 2000.
114. 2+-ATPase. Arch Biochem Biophys 246: 589-601, 1986.
115. Schulman H and Greengard P. Stimulation of brain membrane protein phosphorylation by calcium and an endogenous heat-stable protein. Nature 271: 478-479, 1978.
116. 2+/calmod-ulin-dependent protein kinase II by an autopho-sphorylation mechanism. J Biol Chem 261: 8581-8584, 1986.
117. + pump current in isolated rabbit ventricular myocytes using the whole-cell voltage-clamp technique. Inhibition of the pump by oxidant stress. Circ Res 72: 91-101, 1993.
118. Sirker A, Zhang M, and Shah AM. NADPH oxidases in cardiovascular disease: Insights from in vivo models and clinical studies. Basic Res Cardiol 106: 735-747, 2011.
119. Song Y, Shryock J, Wagner S, Maier LS, and Belardinelli L. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318: 214-222, 2006.
120. 2-induced activation of CaMKII in rat ventricular myocytes. J Mol Cell Cardiol 48: 773-780, 2010.
121. 2+ exchanger in end-stage human heart failure. Circ Res 75: 443-453, 1994.
122. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, and Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278: 35135-35144, 2003.
123. Swaminathan PD, Purohit A, Soni S, Voigt N, Singh MV, Glukhov AV, Gao Z, He BJ, Luczak ED, Joiner ML, Kutschke W, Yang J, Donahue JK, Weiss RM, Grumbach IM, Ogawa M, Chen PS, Efimov I, Dobrev D, Mohler PJ, Hund TJ, and Anderson ME. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest 121: 3277-3288, 2011.
124. Takeishi Y, Ping P, Bolli R, Kirkpatrick DL, Hoit BD, and Walsh RA. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 86: 1218-1223, 2000.
125. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B, Lazzarino G, Paolocci N, Gabrielson KL, Wang Y, and Kass DA. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115: 1221-1231, 2005.
126. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, Feelisch M, and Ma XL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: Role of S-nitrosation. Proc Natl Acad Sci 101: 11471-11476, 2004.
127. Temsah RM, Netticadan T, Chapman D, Takeda S, Mo-chizuki S, and Dhalla NS. Alterations in sarcoplasmic re-ticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol 277: H584-594, 1999.
128. Tsutsui H, Ide T, Hayashidani S, Suematsu N, Utsumi H, Nakamura R, Egashira K, and Takeshita A. Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. Cardiovasc Res 49:103-109, 2001.
129. Tsutsui H, Kinugawa S, and Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 81: 449-456, 2009.
130. Tsutsui H, Kinugawa S, and Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301: H2181-2190, 2011.
131. Valdivia CR, Ueda K, Ackerman MJ, and Makielski JC. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. Am J Physiol Heart Circ Physiol 297: H1446-1452, 2009.
132. Vigil D, Blumenthal DK, Brown S, Taylor SS, and Trewhella J. Differential effects of substrate on type I and type II PKA holoenzyme dissociation. Biochemistry 43: 5629-5636, 2004.
133. Viste K, Kopperud RK, Christensen AE, and Døskeland SO. Substrate enhances the sensitivity of type I protein kinase A to cAMP. J Biol Chem 280: 13279-13284, 2005.
134. + channels. J Clin Invest 116: 3127-3138, 2006.
135. Na augmentation leading to cellular Na and Ca overload. Circ Res 108: 555-565, 2011.
136. Wagner S, Seidler T, Picht E, Maier LS, Kazanski V, Teu-cher N, Schillinger W, Pieske B, Isenberg G, Hasenfuss G, and Kögler H. Na+-Ca+ exchanger overexpression predisposes to reactive oxygen species-induced injury. Cardi-ovasc Res 60: 404-412, 2003.
137. 2+ by phosphorylating troponin I on threonine-144. J Mol Cell Cardiol 41: 823-833, 2006.
138. Wang J, Liu X, Sentex E, Takeda N, and Dhalla NS. Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol. 284: H2277-2287, 2003.
139. Ward CA and Giles WR. Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J Physiol 500: 631-642, 1997.
140. 2+] during the cardiac action potential. Circ Res 90: 182-189, 2002.
141. Weber CR, Piacentino V, 3rd, Houser SR, and Bers DM. Dynamic regulation of sodium/calcium exchange function in human heart failure. Circulation 108: 2224-2229, 2003.
142. Weisser-Thomas J, Piacentino V, 3rd, Gaughan JP, Margu-lies K, and Houser SR. Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovasc Res 57: 974-985, 2003.
143. Xiang Y and Kobilka BK. Myocyte adrenoceptor signaling pathways. Science 300: 1530-1532, 2003.
144. Xie ZJ, Wang YH, Askari A, Huang WH, Klaunig JE, and Askari A. Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump. J Mol Cell Cardiol 22: 911-920, 1990.
145. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 80: 76-81, 1997.
146. Xu L, Eu JP, Meissner G, and Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-s-nitrosylation. Science 279: 234-237, 1998.
147. Yamawaki H, Haendeler J, and Berk BC. Thioredoxin: A key regulator of cardiovascular homeostasis. Circ Res 93: 1029-1033, 2003.
148. 2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes. Car-diovasc Res 77: 432-441, 2008.
149. 1c. Biochemistry 48: 6674-6683, 2009.
150. V1.2 phosphorylation by protein kinase C isoforms. J Biol Chem 280: 207-214, 2005.
151. Zhang M, Brewer AC, Schroder K, Santos CX, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, Brandes RP, and Shah AM. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 107: 18121-18126, 2011.
152. 2+ release in permeabilized rat ventricular myocytes. J Physiol 555: 727-741, 2004.
153. 2+ transients. Circulation 109: 1886-1891, 2004.
154. Zissimopoulos S, Docrat N, and Lai FA. Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein. J Biol Chem 282: 6976-6983, 2007.